GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (NYSE:ENZ) » Definitions » Cyclically Adjusted PB Ratio

ENZ (Enzo Biochem) Cyclically Adjusted PB Ratio : 0.61 (As of Dec. 14, 2024)


View and export this data going back to 1980. Start your Free Trial

What is Enzo Biochem Cyclically Adjusted PB Ratio?

As of today (2024-12-14), Enzo Biochem's current share price is $1.02. Enzo Biochem's Cyclically Adjusted Book per Share for the quarter that ended in Jul. 2024 was $1.66. Enzo Biochem's Cyclically Adjusted PB Ratio for today is 0.61.

The historical rank and industry rank for Enzo Biochem's Cyclically Adjusted PB Ratio or its related term are showing as below:

ENZ' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.58   Med: 1.72   Max: 5.26
Current: 0.61

During the past years, Enzo Biochem's highest Cyclically Adjusted PB Ratio was 5.26. The lowest was 0.58. And the median was 1.72.

ENZ's Cyclically Adjusted PB Ratio is ranked better than
79.84% of 129 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.01 vs ENZ: 0.61

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Enzo Biochem's adjusted book value per share data for the three months ended in Jul. 2024 was $1.074. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.66 for the trailing ten years ended in Jul. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Enzo Biochem Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Enzo Biochem's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem Cyclically Adjusted PB Ratio Chart

Enzo Biochem Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.46 2.09 1.50 0.93 0.69

Enzo Biochem Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.93 0.83 0.77 0.63 0.69

Competitive Comparison of Enzo Biochem's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Enzo Biochem's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzo Biochem's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Enzo Biochem's Cyclically Adjusted PB Ratio falls into.



Enzo Biochem Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Enzo Biochem's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.02/1.66
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzo Biochem's Cyclically Adjusted Book per Share for the quarter that ended in Jul. 2024 is calculated as:

For example, Enzo Biochem's adjusted Book Value per Share data for the three months ended in Jul. 2024 was:

Adj_Book=Book Value per Share/CPI of Jul. 2024 (Change)*Current CPI (Jul. 2024)
=1.074/132.7078*132.7078
=1.074

Current CPI (Jul. 2024) = 132.7078.

Enzo Biochem Quarterly Data

Book Value per Share CPI Adj_Book
201410 0.807 100.176 1.069
201501 0.768 98.604 1.034
201504 0.740 99.824 0.984
201507 0.925 100.691 1.219
201510 1.025 100.346 1.356
201601 1.181 99.957 1.568
201604 1.145 100.947 1.505
201607 1.936 101.524 2.531
201610 1.912 101.988 2.488
201701 1.895 102.456 2.455
201704 1.908 103.167 2.454
201707 1.911 103.278 2.456
201710 1.901 104.070 2.424
201801 1.873 104.578 2.377
201804 1.832 105.708 2.300
201807 1.719 106.324 2.146
201810 1.603 106.695 1.994
201901 1.429 106.200 1.786
201904 1.913 107.818 2.355
201907 1.809 108.250 2.218
201910 1.647 108.577 2.013
202001 1.490 108.841 1.817
202004 1.301 108.173 1.596
202007 1.219 109.318 1.480
202010 1.232 109.861 1.488
202101 1.281 110.364 1.540
202104 1.340 112.673 1.578
202107 1.415 115.183 1.630
202110 1.377 116.696 1.566
202201 1.344 118.619 1.504
202204 1.276 121.978 1.388
202207 1.118 125.002 1.187
202210 0.923 125.734 0.974
202301 0.674 126.223 0.709
202304 0.381 127.992 0.395
202307 1.569 128.974 1.614
202310 1.471 129.810 1.504
202401 1.402 130.124 1.430
202404 1.348 132.289 1.352
202407 1.074 132.708 1.074

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Enzo Biochem  (NYSE:ENZ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Enzo Biochem Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Enzo Biochem's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzo Biochem Business Description

Traded in Other Exchanges
Address
21 Executive Boulevard, Farmingdale, NY, USA, 11735
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
Executives
Steven J Pully director 9800 RICHMOND AVE, SUITE 700, HOUSTON TX 77042
James G. Wolf 10 percent owner 105, FLYWAY DRIVE, KIAWAH ISLAND SC 29455
Hamid Erfanian officer: Chief Executive Officer 527 MADISON AVENUE, NEW YORK NY 10022
Patricia Eckert officer: Interim CFO C/O ENZO BIOCHEM, INC., 81 EXECUTIVE BLVD, SUITE 3, FARMINGDALE NY 11735
Kara Cannon officer: Chief Operating Officer 527 MADISON AVE, NEW YORK NY 10022
Bradley Louis Radoff director 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098
David Bench officer: CHIEF FINANCIAL OFFICER ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Harbert Discovery Fund, Lp 10 percent owner HARBERT DISCOVERY FUND GP, LLC, 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203
Ian B. Walters director ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Mary Tagliaferri director 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158
Clemens Peter J Iv 10 percent owner 2383 N. BERRY'S CHAPEL RD., FRANKLIN TN 37069
Rebecca J. Fischer director ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Fabian Blank 10 percent owner, other: See Remarks ROEMERSTRASSE 6, BAD BERTRICH 2M 56864
Harbert Management Corp 10 percent owner 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203
Harbert Discovery Co-investment Fund I Gp, Llc 10 percent owner 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203